Here’s an update on the treatment journey 4 my #glioblastoma (unfortunately is in poorest prognosis subgroup & has many extra poor prognosis molecular features)! I’m overwhelmed & v thankful for incredible support I’m receiving both medically & across the community! Sydney Local Health District

BREAKING NEWS The 2023 #NobelPrize in Physiology or Medicine has been awarded to Katalin Karikó and Drew Weissman for their discoveries concerning nucleoside base modifications that enabled the development of effective mRNA vaccines against COVID-19.

#OnlineFirst: Read the In the Spotlight commentary— Unraveling #Tcell exhaustion: genetic screening meets in vitro modeling, by Alfred Zippelius, Marcel Trefny, Priska Auf der Maur, and Schmid describing a recent Science Immunology paper from the E. John Wherry group. bit.ly/49iKo2s

SNSF Starting Grants Call 2024 The call is aimed at researchers who intended to apply for an #ERCStartingGrant in 2023 to conduct an independent scientific project and lead a research team in Switzerland. Submission deadline: 1 February 2024 sohub.io/01rm

Our latest story is out in @CellPressImmunity today!! We show that Stat5 opposes Tox and rewires exhausted CD8s towards more durably protective effector-like states. Shout out to my co-authors, Parker Institute for Cancer Immunotherapy and E. John Wherry Key take-home messages in the 🧵⬇️ cell.com/immunity/ppt/S…

New #JITC position article and guidelines: Corticosteroid-resistant immune-related adverse events: a systematic review bit.ly/3u0egRp Heinz Läubli Alfred Zippelius @cappelliMD Jarushka Naidoo

WithersLab Colin Lee Clatworthy Lab Congrats WithersLab and Clatworthy Lab! Still impressed how rapidly NKs change in the TME

Merci++ à Jennifer Blum et Emmanuel Ostia

New immune cell engagers for cancer immunotherapy | Nature Reviews Immunology nature.com/articles/s4157…

Amazing joint achievement ! BinderLab Minguet_lab and Chiorazzi Lab Nature Communications UniSpitalBaselCH CIBSS Florian Märkl Sophia Stock Ignazio Piseddu

This is great news for T cell therapies for cancer. nbcnews.com/health/health-…

Great work by Ronja Wieboldt and Natalia Mantuano in our lab Department of Biomedicine . They show that myeloid-derived suppressors are inhibiting efficient anti-tumor immunity by secreting CCL2 induced by sialic acid-Siglec interactions. #glycotime rdcu.be/dAt5I

Happy to present our 'Expert Opinion' on "CAR T cells for solid tumors – developments to watch in 2023" tandfonline.com/doi/full/10.10… LMU Clinical Pharmacology

.Lurie Cancer Center’s 2024 Translational Research in Malignancies Symposium was a great success! Thank you to all of today’s speakers for their insights focused on resistance to cancer treatment. View the topics here: cancer.northwestern.edu/docs/event-doc…

TODAY is the #SITC Summit on #Immunomodulation of #ADCs at 11 a.m EDT. Organizers TimLowinger Sara Tolaney & Alfred Zippelius will discuss the current state and future of the field. There's still time to register for FREE! Save your spot for today's summit: go.sitcancer.org/3J157vT

Excited to share that our story on PGE2-mediated control of NK cell metastasis surveillance in lung tissue is now published in Cell Reports 🤝 Thanks to the many great colleagues who helped conduct this study! 👏Congratulations to first author @AMPedde! cell.com/cell-reports/f…

New #JITC article: Inhibition of Cbl-b restores effector functions of human intratumoral NK cells bit.ly/3CCabqI Alfred Zippelius

Snow much joy at @MagdalenOxford 🦊 🎥 | Eleonora Svanberg #OxfordInSnow

Would you prefer to lead a lab alone or together with a science buddy? How interesting would be a research institute where joint labs are the standard?!